追蹤
Chun-Chun Chang
Chun-Chun Chang
花蓮慈濟醫院檢驗醫學科
在 gms.tcu.edu.tw 的電子郵件地址已通過驗證
標題
引用次數
引用次數
年份
A potential peptide derived from cytokine receptors can bind proinflammatory cytokines as a therapeutic strategy for anti-inflammation
SJ Jiang, PI Tsai, SY Peng, CC Chang, Y Chung, HH Tsao, HT Huang, ...
Scientific reports 9 (1), 2317, 2019
262019
Peptides derived from CXCL8 based on in silico analysis inhibit CXCL8 interactions with its receptor CXCR1
SJ Jiang, JW Liou, CC Chang, Y Chung, LF Lin, HJ Hsu
Scientific reports 5 (1), 18638, 2015
252015
Internal water channel formation in CXCR4 is crucial for Gi-protein coupling upon activation by CXCL12
CC Chang, JW Liou, KTP Dass, YT Li, SJ Jiang, SF Pan, YC Yeh, HJ Hsu
Communications Chemistry 3 (1), 133, 2020
192020
A Sequence in the loop domain of hepatitis C virus E2 protein identified in silico as crucial for the selective binding to human CD81
CC Chang, HJ Hsu, JH Yen, SY Lo, JW Liou
PloS one 12 (5), e0177383, 2017
152017
Hepatitis C virus core protein: Not just a nucleocapsid building block, but an immunity and inflammation modulator
H Mani, JH Yen, HJ Hsu, CC Chang, JW Liou
Tzu Chi Medical Journal 34 (2), 139-147, 2022
62022
Computer-aided discovery, design, and investigation of COVID-19 therapeutics
CC Chang, HJ Hsu, TY Wu, JW Liou
Tzu Chi Medical Journal 34 (3), 276-286, 2022
52022
The perspectives of interleukin-10 in the pathogenesis and therapeutics of multiple myeloma
CD Liu, CC Chang, WH Huang
Tzu Chi Medical Journal 33 (3), 257-262, 2021
42021
Valine-279 Deletion–Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub …
MC Chen, YC Hsiao, CC Chang, SF Pan, CW Peng, YT Li, CD Liu, ...
Biomedicines 9 (3), 301, 2021
22021
Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation
CC Chang, CD Liu, SF Pan, WH Huang, CW Peng, HJ Hsu
Tzu Chi Medical Journal 32 (3), 245-253, 2020
22020
Therapeutic peptide RF16 derived from CXCL8 Inhibits MDA-MB-231 cell invasion and metastasis
CM Chang, CC Chang, HYP Lam, SY Peng, YH Lai, BD Hsiang, YY Liao, ...
International Journal of Molecular Sciences 24 (18), 14029, 2023
12023
In silico study on the internal signal pathway of different mutants of vasopressin receptor 2 with arginine vasopressin bound
TY Hu, HJ Hsu, CC Chang
Biophysical Journal 122 (3), 198a-199a, 2023
2023
A Multitarget Therapeutic Peptide Derived From Cytokine Receptors Based on in Silico Analysis Alleviates Cytokine-Stimulated Inflammation
CC Chang, SY Peng, HH Tsao, HT Huang, XY Lai, HJ Hsu, SJ Jiang
Frontiers in Pharmacology 13, 853818, 2022
2022
Combinatorial Virtual Screening Revealed a Novel Scaffold for TNKS Inhibition to Combat Colorectal Cancer
CC Chang, SF Pan, MH Wu, CT Cheng, YR Su, SJ Jiang, HJ Hsu
Biomedicines 10 (1), 143, 2022
2022
Valine-279 Deletion–Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub …
MC Chen, YC Hsiao, CC Chang, SF Pan, CW Peng, YT Li, CD Liu, ...
s Note: MDPI stays neutral with regard to jurisdictional claims in published …, 2021
2021
In silico and in vitro studies on the activation and signaling mechanisms of CXCL12 binding to its cognate receptor CXCR4
CC Chang, KTP Dass, SJ Jiang, HJ Hsu
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 256, 2018
2018
In Silico Identification of Binding Sites Responsible for Species Specificity on Human CD81 and Hepatitis C Virus E2 Protein
CC Chang, HJ Hsu, JW Liou
Biophysical Journal 110 (3), 528a, 2016
2016
Peptides Derived from CXCL8 Based on in Silico Analysis Inhibit CXCL8 Interactions with its Receptor CXCR1
CC Chang, SJ Jiang, JW Liou, Y Chung, HJ Hsu
Biophysical Journal 110 (3), 543a, 2016
2016
系統目前無法執行作業,請稍後再試。
文章 1–17